Abbott to Buy Cancer-Screener Exact Sciences for $21 Billion

Abbott Laboratories agreed to acquire cancer-screening company Exact Sciences Corp., in a deal with a total equity value of about $21 billion.

By Michelle F Davis, Dinesh Nair · Bloomberg Markets

Abbott Laboratories agreed to acquire cancer-screening company Exact Sciences Corp., in a deal with a total equity value of about $21 billion.